New Zealand markets closed

Avidity Biosciences, Inc. (RNA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
29.62+0.11 (+0.37%)
At close: 04:00PM EDT
29.52 -0.10 (-0.34%)
After hours: 07:59PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-228,681
-212,220
-173,995
-118,009
-44,355
-
Depreciation & amortisation
2,351
2,101
1,387
639
373
-
Stock-based compensation
39,424
38,222
27,139
17,056
4,310
-
Change in working capital
55,314
61,129
7,067
4,643
2,332
-
Accounts payable
3,186
1,769
18,315
6,043
5,749
-
Other working capital
-143,800
-123,292
-139,091
-98,553
-38,209
-
Other non-cash items
3,118
2,978
2,749
679
214
-
Net cash provided by operating activities
-140,477
-119,064
-136,268
-94,813
-37,117
-
Cash flows from investing activities
Investments in property, plant and equipment
-3,323
-4,228
-2,823
-3,740
-1,092
-
Purchases of investments
-351,209
-461,002
-355,837
-85,357
-6,693
-
Sales/maturities of investments
387,395
335,160
168,705
6,580
0
-
Net cash used for investing activities
32,863
-130,070
-189,955
-82,517
-7,785
-
Cash flows from financing activities
Debt repayment
-
-
0
0
-4,683
-2,800
Common stock issued
282,347
60,547
344,779
174,677
274,054
-
Dividends paid
-
-
-
0
0
-106
Other financing activities
-
-
-
-11,262
-24,026
-
Net cash used provided by (used for) financing activities
460,348
93,864
346,171
176,316
272,037
-
Net change in cash
352,734
-155,270
19,948
-1,014
227,135
-
Cash at beginning of period
118,961
340,647
320,699
321,713
94,578
-
Cash at end of period
471,695
185,377
340,647
320,699
321,713
-
Free cash flow
Operating cash flow
-140,477
-119,064
-136,268
-94,813
-37,117
-
Capital expenditure
-3,323
-4,228
-2,823
-3,740
-1,092
-
Free cash flow
-143,800
-123,292
-139,091
-98,553
-38,209
-